Impact BioMedical (IBO) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for November 5, 2025, to elect eight directors, ratify the auditor, and hold an advisory vote on executive compensation.

• Proxy materials, including the annual report and proxy statement, are available online and by mail.

• Record date for voting is September 8, 2025, with 12,185,412 shares of common stock outstanding.

Voting matters and shareholder proposals

• Proposals include election of eight directors, ratification of Grassi & Co. as auditor, and a non-binding say-on-pay vote.

• Board recommends voting FOR all proposals.

• Shareholders may submit proposals for the 2026 meeting by March 5, 2025, following SEC and bylaw requirements.

Board of directors and corporate governance

• Board consists of eight nominees with diverse backgrounds in law, banking, biotech, and corporate management.

• Committees include Audit, Compensation, and Nominating & Corporate Governance, all established in September 2023.

• Code of Business Conduct and Ethics adopted and available on the company website.

• No legal proceedings involving directors or officers in the past 10 years.